Oroxine 50 microgram tablets
*Company:
AspenStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 04 September 2024
File name
DC1225_Levo_Tab_IE_S_50mcg_v5.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 04 September 2024
File name
DC1225_Levo_Tab_IE_P_Combined_v15.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
Updated on 25 September 2023
File name
DC1225_Levo_Tab_IE_P_Combined_v14.pdf
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
Updated on 25 September 2023
File name
DC1225_Levo_Tab_IE_P_Combined_v14.pdf
Reasons for updating
- New PIL for new product
Updated on 25 September 2023
File name
DC1225_Levo_Tab_IE_S_50mcg_v4.pdf
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 08 February 2023
File name
DC1225_Levo_Tab_IE_S_50mcg_v3.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)